Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-12-06

Clinical Trial Update: Pharmacokinetics Of Tigecycline In Morbidly Obese Subjects [Phase 4]

View source ↗

Summary

A Phase 4 pharmacokinetic study evaluated tigecycline exposure in morbidly obese subjects to better understand dosing in this population.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TYGACIL (tigecycline)

Snippet

Sponsor: Manjunath Prakash Pai | Conditions: Obesity | Phase 4 | Status: COMPLETED | Results posted: 2016-12-06